VRC is proud to release its latest industry report. The report provides a concise, insightful update on the Biotechnology industry including recent transactions, market multiples, company performance and purchase price allocation percentages.

Industry Highlights

• On September 28, 2024, Regeneron Pharmaceuticals purchased Quad/Graphic’s
  nearly 1.1 million-square-foot plant, igniting hopes for the replacement of a major industrial operation that pulled up stakes earlier this year. Regeneron, based in Tarrytown, NY, develops and manufactures a variety of prescription medications.
• On January 23, 2025, AbbVie completed the previously announced acquisition of Nimble Therapeutics for approximately $200 million. Nimble’s lead asset is an investigational oral peptide IL23R inhibitor in preclinical development for the treatment of psoriasis.

Past Industry Updates

Biotechnology: July 2024

Biotechnology: February 2024